X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (304) 304
Publication (18) 18
Conference Proceeding (17) 17
Book Chapter (12) 12
Book Review (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
index medicus (85) 85
female (68) 68
analysis (48) 48
adult (41) 41
middle aged (40) 40
mathematical models (39) 39
pathology (38) 38
fuzzy systems (37) 37
computer science, artificial intelligence (34) 34
uncertainty (34) 34
automation & control systems (33) 33
fuzzy logic (32) 32
oncology (32) 32
engineering (31) 31
stability analysis (31) 31
studies (31) 31
control systems (29) 29
fuzzy (29) 29
design (28) 28
aged (27) 27
diagnosis (27) 27
fuzzy control (27) 27
mathematical analysis (26) 26
operations research & management science (26) 26
engineering, electrical & electronic (25) 25
male (25) 25
tumors (25) 25
algorithms (24) 24
model (24) 24
optimization (24) 24
uncertain systems (23) 23
stabilization (22) 22
computer simulation (21) 21
stability (21) 21
artificial intelligence (20) 20
uncertain grades (20) 20
classification (19) 19
fuzzy set theory (19) 19
management (19) 19
mutation (19) 19
decision making (18) 18
decision-making (17) 17
linear matrix inequalities (17) 17
models (17) 17
uncertain significance (17) 17
aged, 80 and over (16) 16
breast cancer (16) 16
cancer (16) 16
identification (16) 16
leiomyosarcoma (16) 16
obstetrics & gynecology (16) 16
research (16) 16
subject (16) 16
genetics & heredity (15) 15
h-infinity control (15) 15
linear matrix inequality (15) 15
methods (15) 15
nonlinear-systems (15) 15
risk (15) 15
surgery (15) 15
usage (15) 15
uterine neoplasms - pathology (15) 15
relaxed stability (14) 14
retrospective studies (14) 14
uterus (14) 14
adolescent (13) 13
computer science, theory & methods (13) 13
fuzzy sets (13) 13
lesions (13) 13
linguistics (13) 13
nonlinear systems (13) 13
performance (13) 13
predictive value of tests (13) 13
prognosis (13) 13
cell biology (12) 12
computer science (12) 12
diagnosis, differential (12) 12
dynamical systems (12) 12
immunohistochemistry (12) 12
information (12) 12
mechanical engineering (12) 12
smooth muscle (12) 12
computational intelligence (11) 11
genes (11) 11
intervals (11) 11
risk factors (11) 11
sarcoma (11) 11
vaginal smears (11) 11
young adult (11) 11
brca1 (10) 10
cytogenetics (10) 10
delay (10) 10
leiomyoma (10) 10
observers (10) 10
uncertain malignant potential (10) 10
article (9) 9
biopsy (9) 9
breast (9) 9
care and treatment (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015 IEEE International Conference on Grey Systems and Intelligent Services (GSIS), ISSN 2166-9430, 08/2015, Volume 2015-, pp. 333 - 338
Contemporarily, for the evaluation of enterprise credit, many specific value of indexes are difficult to be obtained, so decision makers tend to give a form of... 
enterprise credit | group decision making | core | grey relational grade | Decision making | greyness of degree | interval grey number | uncertain linguistic
Conference Proceeding
Sensors (Switzerland), ISSN 1424-8220, 04/2014, Volume 14, Issue 4, pp. 6584 - 6605
Journal Article
2009, ISBN 9780784409961
In the last few years, many researchers have studied the vehicle routing problem (VRP) in logistic studies, however, the majority of those analyses have gone... 
Uncertain demand | VRP | Fuzzy theory | Preference grade
Book Chapter
International Journal of Surgery Case Reports, ISSN 2210-2612, 2015, Volume 17, pp. 82 - 84
Highlights • Prostatic stromal sarcomas account for about 0.1% of all prostatic malignancies. • The preferred treatment is surgery by radical prostatectomy or... 
Surgery | Malignancy | Skin | Metastasis | Sarcoma | Stromal tumours of uncertain malignant potential (STUMP) | Prostate
Journal Article
Histopathology, ISSN 0309-0167, 06/2003, Volume 42, Issue 6, pp. 631 - 633
invasive ductal carcinoma | magnetic resonance | oligodendroglioma | salivary duct carcinoma | radiology | t(14;18) | gastrointestinal neoplasms | cytogenetics | myofibroblastic neoplasms | c‐erbB‐2 | video‐conferencing | Ewing's sarcoma | neoplasia | nodular lesions | cyclin E | white pulp | dermatomyofibroma | c‐erbB‐2 protein | HER2 gene amplification | human spleen | virtual double‐headed microscope | mucin | cyclin A | Alzheimer's disease | age factor | glutamate | androgen | sampling methods | storage disease | VS38c | quality control | non‐cirrhotic portal hypertension | endometriosis | microvessel densities | pneumatosis | HIV‐associated lymphoma | myeloproliferative disorders | teaching materials | growth factor | pathogenesis | Pipelle endometrial biopsy | oesophageal Paget's disease | cellular differentation | HER‐2 neu | processing | myofibroblastoma | photography | essential thrombocythaemia | plasmablastic lymphoma | synovial sarcoma | fibrinogen | nodular | lectin | smooth muscle | videotape recording | thyroid cancer | endometrial adenocarcinoma | sarcomatoid carcinoma | Chk2 | vulva | angiography | mucin expression | minimal deviation | specificity | maspin | mesothelioma | germ cell | CD31 | laparoscopy | androgen receptors | smooth muscle cell | complications | tumours of soft tissue | α‐catenin | endoscopy | 4‐hydroxy‐2′‐nonenel | 8‐hydroxydeoxygnanosine | prognosis | lichen sclerosus | tissue microarrays | CD79a | cholesteatoma | urothelial carcinoma | neurone‐specific enolase | mass lesions | telemicroscopy | myocardial remodelling | FISH | cyclin D1 | information | Herception | extracellular matrix | needle biopsy | oxidative stress | inflammatory myofibroblastic tumour | mucinous carcinoma | partial nodular transformation | ethics | gastric metaplasia | research | hyperplasia metaplastic polyp | antigen retrieval | informed consent | cyclooxygenase‐2 | h‐caldesmon | S100 | antibodies | cytokeratin 7 | Ki67 | microsatellite repeats | hypoxia | idiopathic portal hypertension | MIB‐1 | Langerhans cell histiocytosis | malignant mesothelioma | AIDS | graft‐versus‐host disease | suspicious | neurodegenerative disorders | topoisomerase IIα | Barrett's oesophagus | subjective assessment | reactive | thyroid | breast carcinoma | intestinal metaplasia | epithelial cyst | CK20 | gland neoplasms | fibrin | oesophageal | hamartoma | CD44 | dementia with Lewy bodies | oestrogen | gastric | marginal zone | histopathology | privacy | standardization | apocrine carcinoma | CD44v6 | progesterone receptor | CK7 | RT‐PCR | reactive mesothelial hyperplasia | verbal autopsy | extramammary Paget's disease | electron microscopy | image improvement | tumorigenesis | proliferation index | leiomyoma | regenerative nodular hyperplasia | normal | immunoelectron microscopy | myocardial | poorly differentiated carcinomas | oesophageal adenocarcinoma | breast cancer | colorectal carcinoma | hepatoportal sclerosis | p53 protein | γ‐catenin | sialic acid | FIGO grade | Kaposi's sarcoma | albumin | high molecular weight cytokeratin | Ki67 antigen | Fas | microvascular architecture | cyclin | mucous gland carcinoma | hereditary haemorrhagic telangiectasia | p53 | division | lung cancer | oval cells | uterus | endometrial | serrated adenoma | guidelines | hyperplasia | nodular regenerative hyperplasia | hepatocellular carcinoma | fusion proteins | colorectal cancer | liver | angiogenesis | diverticular disease | smooth muscle cells | dysplastic nodules | alcoholic liver disease | leiomyoblastoma | prognostic marker | cytokeratins | bronchioloalveolar carcinoma | Fas‐L | background compensation | oestrogen receptors | sensitivity | spermatocytic seminoma | fetus | Goseki | skin | post mortem | quantitative measurements | carcinoids | Paget's disease | histochemistry | metastasis | stromo‐epithelial lesions | COX‐2 | gelatin‐binding protein of 28 kDa (adiponectin) | HMGI(Y) expression | caldesmon | calponin | p19INK4d | calibration | oesophageal carcinoma | gastric cancer | proliferation | cell cycle | presumed consent | reproducibility | endometrium | epithelioid haemangioendothelioma | adenocarcinoma | basal cell adenocarcinoma | personal autonomy | radiography | uncertain maligant potential | digital microphotography | Philadelphia chromosome | ductal carcinoma in situ | histological grade | telepathology | endometrial curettings | HIV | GCDFP‐15 | MDM2 | N‐acetylaspartate | ALK | sarcoma | myofibroblast | 34βE12 | myocardial infarction | cytokeratin | non‐Hodgkin's lymphoma | stomach neoplasms | transitional cell carcinoma | E‐cadherin | androgen receptor | gastric adenocarcinoma | TUNEL | colorectal | ulcerative colitis | pleura | globus pallidus | cytokine | portal hypertension | growth patterns | TFF‐peptides | desquamative interstitial pneumonia | stem cell transplantation | acute hepatic damage | diagnosis | lymphocyte‐rich stroma | MIB‐1 (Ki67) | multiple system atrophy | liver cirrhosis | embryonic lesion | β‐catenin | chromosome 3 | lobular carcinoma in situ | cervical dyskaryosis | glycoprotein | κ statistics | autopsy | coroner | MCM2 | bcr‐abl | skin metastasis | magnetic resonance imaging | differentiation | pathology | neoplasms of pleura and lung | elderly | abundance | progesterone | progesterone receptors | apoptosis | oestrogen receptor‐α | ossifying fibromyxoid tumour | oestrogen receptor‐β | red pulp | mimicry | MAGE‐A4 | neuroendocrine tumours | immunohistochemistry | testicular neoplasm | cirrhosis | Epstein–Barr virus | erythropoietin | follicular lymphoma | reactive pleural fibrosis | VEGF | Crohn's disease | chronic inflammatory bowel disease | incomplete septal cirrhosis | prostate cancer | focal nodular hyperplasia | macroregenerative nodules | craniopharyngioma | keratin | arithmetical operation | patient rights | growth | breast
Journal Article
Korean Journal of Obstetrics & Gynecology, ISSN 2233-5188, 12/2012, Volume 55, Issue 12, pp. 996 - 1000
A 57-year-old Korean woman visited 37 months after initial surgery with fetal head sized pelvic mass. Initially, she underwent total abdominal hysterectomy... 
Recurrence | Uterine smooth muscle tumor of uncertain malignant potential | Leiomyosarcoma | 산부인과학
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2003, Volume 120, Issue 6, pp. 1100 - 1103
androgens | ABO incompatibility | graft‐versus ‐plasma cell effect | telomere | Z deficiency | t(14;18) | acutemyeloid leukaemia | α‐thalassaemia | childhoodAPL | plateletshape change | T‐cell lymphoma | UMPH deficiency | karyotype | prognosticmodel | stomatocytosis | cyclophosphamide | eosinophilia | cobalamin deficiency | doxorubicin | Factor VIIa | leukaemogenesis | Burkitt'slymphoma | antifactor VIII antibody | 52Fe | PML/RARα | non‐homologous recombination | endocytic vesiculation | cardiolipin | bFGF | Aiolos | autoimmunethrombocytopenic purpura | irondeficiencyanaemia | chelation | proteinS | monoclonal gammopathy ofunknown significance | CD2 expression | acute lymphoblastic leukaemia | CD45isoforms | drug resistance | NUP98 | adult | childhoodcancer | treatment | plasmaexchange | recombinant | multicentric Castleman's disease | myelomaanimal model | NF‐κB inhibitor | venous | myeloma | haemostasis | bloodsubstitutes | enoxaparin | autoimmune idiopathic thrombocytopenic purpura | point mutation | fluorescence in situ hybridization | catheter‐relatedthrombosis | long haul flights | TCR‐γ | vasculitis | cytotoxic CD8 | TCR‐β | sex | blood | congenital bleeding disorder | bone marrow | skin rash | idiopathic myelofibrosis | MALT lymphoma | genetichaemochromatosis | autologous | monoclonal gammopathy ofundetermined significance | severe | solubleurokinase‐type plasminogen activator  receptor (suPAR) | translocation4;14 | resorption | clinical features | beta2‐glycoprotein I | gemcitabine | plasma | long‐term follow‐up | real‐time quantitativereverse‐transcription polymerase chain reaction | Danny Thomas | immunohaematological reconstitution | ironpolymaltose | screening | type 2M VWF | polycythaemia vera | T‐cellreceptor | autologous stem cell transplantation | immunosuppressive drugs | APC resistance | bonedensity | IL‐8/CXCL8 | aplastic anaemia | l‐arginine | sialoadhesin | thalidomide | chromosome 13 | recombinant ADAMTS13 | childhoodAML | protein C | autoimmune | STI571 | factorVII | chromosomes | Rituximab | primary progressive | soluble | RTK class III | Ikaros | guideline | transplantation | acutepromyelocytic leukaemia | economy class syndrome | P‐selectin | ferritin | Meningococcal sepsis | methionine synthase | ADP receptors | standardization | training | allogeneicstem cell transplantation | HOXD11 | RT‐PCR | fibrinogen Aα chain | prognosticindicators | Giovanni Di Guglielmo | integrin beta‐1 | β2m‐free HLA class I heavy chain | HHV‐8‐encoded viral homologues of cellular genes | human | bone marrowtransplantation | bcr‐abltranscript | haemochromatosis | translocation | graft‐versus ‐host disease | lymphoma | breast cancer | Gleevec | stroke | real‐time quantitative | FLT3 internal tandem duplication | idiotype | p38 MAP kinase | management | treatment‐related toxicity | PEL | synthase | iron | platelet | cancer | age | killing inhibitory receptor | factor IX gene | monocytic leukaemia zinc finger protein‐related factor gene | transferrinsaturation | C282Y mutation | CLL | in vivo imaging | perforin | bleeding | sickle | therapy‐relatedmyelodysplastic syndrome | B lymphocytes | transferrin | CD40/CD40L | stem celltransplantation | chemotherapy | fluorescencemicroscopy | severe aplastic anaemia | reactive T cells | SLL | normalization | stemcells | hairy cell leukaemia | spectratype | guidelines | activatedprotein C | CMK | granulocyte colony‐stimulating factorreceptor | osteolytic bone destructions | CML | angiogenesis | activated factor VII | polycythaemia veramanagement | quantitative real‐time PCR | antiphospholipid antibodies | deferiprone | mutation | haplotypes | hypogonadism | megakaryoblastic cell line | HS‐40 | obligate heterozygotes | tumourantigen | leukaemia | Hodgkin's disease | T‐LGL | real‐time quantitativereverse transcription polymerase chain reaction (PCR) | imatinib mesylate | basophilic leukaemia | dysfunction | myelodysplasia | haemolytic anaemia | SCID mouse | sicklecell disease | tumour | venousthromboembolism | Ca2+ ionophore | c‐fms | haemophilia | blood stem cells | transplant | outcome | lipopolysaccharide (LPS) | plateletglycoprotein Ib | orthopaedic surgery | leucocytes | high‐dose therapy | interleukin 2 2 (IL‐2) | hydroxyurea | BCL6 | plateletsize heterogeneity | lymphoproliferativedisorder | BCL2 | hypercoagulable state | granulocyte‐macrophage colony stimulating factor (GM‐CSF) | rhodamine | Donald Pinkel | ALL | granzyme B | FLT3 | adultALL | polymorphism | transfusion | immunocompromised | LSP1 | non‐Hodgkin's lymphoma | amino‐terminal telopeptide of collagen type I | dendritic cell (DC) | mast cells | CD11c | E‐cadherin | t(1;19) translocation | imatinib mesylate (Glivec, Gleevec) | paediatrics | haematological malignancies | mutations | OHK | fluorescence | von Willebranddisease | T‐LGLleukaemia | NOD/SCID mice | puberty | erythropoiesis | single nucleotide polymorphisms | chronic | desmopressin | haemoglobin ‐based oxygen carrier Hemolink | AML | peripheral | multiple myeloma | endogenouserythroid colony growth | signal transduction | therapy‐related | beta‐2 glycoprotein 1 | diagnosis | Cos‐7 cells | t(2;11)(q31;p15) | VWF‐cleaving protease | acutemyelomonocytic leukaemia | clinical | lead poisoning | methylenetetrahydrofolate reductase | target antigens | erythroblasts | unstable angina | ATRA | paroxysmal nocturnal haemoglobinuria | E2A–PBX1 | intracellular Ca2 | chemokine | differentiation | GVHD prophylaxis | PRCA | elderly | leucocyte | anticoagulation | apoptosis | HLA molecules | Burkitt‐like | GATA‐1 | von Willebrand | Di Guglielmo's syndrome | triathlon | TTP | oxidative burst | telomerase | Bernard–Soulier syndrome | leucopenia | nitric oxidemetabolites | cisplatin | N‐glycosylation | erythropoietin | endothelium | p‐glycoprotein | proteindegradation | follicular lymphoma | sports | CNS infiltration | DDAVP | miscarriage | air travel | control | acutemyeloid leukaemia (AML) | myeloidproliferative disease | first remission | prothrombin deficiency | Beta‐2‐glycoprotein I | NK cell | Fanconi's anaemia | mu class isoforms | ataxia‐telangiectasia | CTL | irondepletion | autoimmunelymphoproliferative syndrome | activated | haemophiliaB | megaloblastic anaemia | myeloproliferativedisorders | photosensitivity | ironoverload | PNH | cytogenetics | M3 variant | ischaemic stroke | Japanese cord blood bank network | twin study | pregnancycomplications | catheter‐related | protein | glutathione S‐transferases | homing | monoclonal gammopathy of uncertain significance | bloodmononuclear cells | cord blood transplantation | tamoxifen | Helios | short isoform | peptide | relapse | pregnancy | molecular response | prognostic factor | platelets | LGL | vaso‐occlusive crisis | lymph nodes | t(3;14) | erythema nodosum | pyruvate kinase deficiency | stem cell collection | plateletactivation and function | dendritic cell | essential thrombocythaemia | lymphoproliferative disease of granular lymphocytes | CD20 | endogenous | immune deficiency | refractory anaemia | Fcγ receptors | haemolytic | cell activation | chest crisis | irondeficiency | genetic associations | recombinantprotein | imatinib mesylate(Glivec | TCR/CD3 protein | diversity | dendritic celldepigmentation | vinblastine | allogeneic | haematological malignancy | mantle cell lymphoma | monoclonal gammopathy of | MTFHR MTHFR | severecongenital neutropenia | prognosticfeatures | genetic | CD30 | adultT‐cell leukaemia | childhood | complications | trisomy 21 | prognosis | haematopoiesis | cation leak | catheter‐related infection | erythrocytosis | desferrioxamine | haemoglobinraffimer | t(11;18) | immunoglobulin variable region genes | FISH | dysprothrombinaemia | myelodysplastic syndrome | somatic mutation | standard therapy | centralnervous system relapse | pharmacokinetic study | transient leukaemia | T‐celllarge granular lymphocyte leukaemia | tissue factor | centralvenous catheter | brachydactyly type C | haematopoietic | CD27–CD70 interaction | CD38 | antisickling agents | 59Fe | CD35 | CD34 | chroniclymphocytic leukaemia | IL‐4 | antithymocyte globulin | endogenousthrombin potential | neutropenia | haemolyticuraemic syndrome | NOS inhibitor | chronicmyeloid leukaemia (CML) | nucleotidase | IL‐15 | systemic mast cell disease | genotype | folate | T‐prolymphocytic leukaemia (T‐PLL) | serine/threonine phosphorylation | hypoprothrombinaemia | TNF‐α transcription | instability | cardiolipinbinding | plateletfunction | haematopoietic cell transplantation | CD45 | CD43 | DNA sequencing | gestational thrombotic miroangiopathic anaemia | α‐globin gene | clopidogrel | chronic graft‐versus‐host disease | clinicalmanagement | T‐cellacute lymphoblastic leukaemia (T‐ALL) | haematopoieticstem cell transplantation | adults | T‐cell | thrombus precursor protein | modified CHOP chemotherapy | gag | cutaneous T‐cell lymphoma (CTCL) | therapy‐related acute myeloid leukaemia/myelodysplasia | epidemiology | minimal | central | thrombosis | CXCR1 | BNLI | CD59 | cytopenia | factor | isotype switching | MTHFRC677T | PFA‐100 | harvest | pain | risk factor | bonepain | P5 N deficiency | high‐grade transformation | genotypes | SLVL | bone | p15 methylation | polymorphisms | parvovirus B19 | neurological dysfunction | flt3‐ligand | G‐CSF | deep vein thrombosis | deficiency | haemolysis | T‐ALL | immunophenotype | myeloproliferative | tumournecrosis factor‐alpha (TNF‐α) | morphological dysplasia | MIP‐1α | risk | cell–cell interaction | extramedullary relapse | mean platelet volume | CD86 | minimalresidual disease (MRD) | Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia | CD80 | HFE | analgesia | anti‐thymocyte globulin | graft‐versus ‐leukaemia effect | adultT‐cell leukaemia/lymphoma | p53 | paediatric | humanherpesvirus 6 | large‐volume leukapheresis | haemoglobin | high‐risk febrile neutropenia | myeloid leukaemia | children | deletion | menstruation | manganese superoxide dismutase | cytokines | flow cytometry | splenectomy | PDGFRB | nitric oxide | quantification | anti‐phospholipid syndrome (APS) | gene | FLT3/ITD | glycosylation | soluble HLA‐I | ultrastructure | recombinantVIIa | peak bone mass | co‐stimulatory molecules | tandem transplants | non‐myeloablative | low‐risk febrile neutropenia | thrombin generation | antibiotics | telomeremetabolism | CD88 | CD87 | Factor VII/VIIa | infection | minimalconditioning | TIA‐1 | erythrocytes | proteasome inhibitor | unrelated donor | T‐cellimmunophenotype | chronicmyeloid leukaemia | apoptotic apoptoticcells | carboxy‐terminal telopeptide of collagen type I | apoptoticgenes | gemtuzumab ozogamicin | chronicmyelogenous leukaemia | translocation(10;16) | pyridinolines | HS‐33α major regulatory element | managementguidelines | HIV | phagocyte activation | sicklecell anaemia | factor XIII | regimen‐related toxicity | statistical analysis | Alu‐associated homologous recombination | FGFR3 | mesenchymal cells | venousthrombosis | Burkitt's | childhoodITP | red cell utilization | positron emission tomography (PET) | bone marrowmicroenvironment | Siva | myocardial infarction | gene expression | microangiopathic haemolytic anaemia | innate immunity | menopause | interleukin 2 | genetransfer | activatedprotein C(APC) resistance | conditioning regimens | cone and plate(let) analyser | crisis | graft‐versus ‐lymphoma effect | hyaluronan | survival | CREB binding protein gene | blood coagulation | c‐kit | prognostic | CD45 (LCA) | thrombophilia | myeloproliferative disorder | complete remission | fludarabine | von Willebrandfactor | neuropathy | malignant lymphoma | acute | bcr‐abl | GPIb | pathology | thalassaemia | thrombocytopenia | allogeneichaematopoietic stem‐cell transplantation | idiotypevaccination | case report | INR | TFPI | β‐thalassaemia | Hashimoto's thyroiditis | low leucocyte count | integrins | MUC1 | respiratory symptoms | autologoustransplantation | GPI anchor | Helicobacter pylori | myeloid | plateletperoxidase | stem cell | immunotherapy | allogeneicbone marrow transplantation | glucocorticoids | immunohistochemistry | plasma cell purification | tyrosine phosphorylation | interleukin | α thalassaemia | peripheral blood mononuclear cells | HHV‐6 | bonelesions | ζ chain | anaemia | interleukin8 | endothelial cell | riskfactors | human herpesvirus‐8 | lymphoproliferative | myeloperoxidase | thrombotic thrombocytopenic purpura | intracranial haemorrhage | MEGO1 | extra‐gastric | erythroleukaemia | granulocyte colony‐stimulating factor | high‐resolution computerized tomography | investigation | leukaemic pulmonary infiltrates | SCL
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2015, Volume 33, Issue 4, pp. 304 - 311
Journal Article
International Journal of Intelligent Systems, ISSN 0884-8173, 10/2019, Volume 34, Issue 10, pp. 2521 - 2555
Journal Article
Physics Letters A, ISSN 0375-9601, 2004, Volume 326, Issue 5, pp. 333 - 339
This Letter investigates the design of coupling functions for global synchronization of uncertain dynamical networks. Some coupling functions are constructed... 
Chaos | Uncertain system | Global synchronization | Network | 05.40.Xt | 05.45.Gg | uncertain system | global synchronization | chaos | PHYSICS, MULTIDISCIPLINARY | network
Journal Article
Cancer Research, ISSN 0008-5472, 08/2017, Volume 77, Issue 16, pp. 4517 - 4529
Journal Article